The FDA approved treosulfan (Grafapex) with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell ...

The U.S. Food and Drug Administration banned Red No. 3 last dye, leading those to think Red Dye No. 40 could be next. How are ...

GRAIL is advancing blood-based cancer detection with Galleri. Find out why GRAL stock’s future hinges on successful trials ...

The test employs a combination of tumour-agnostic next-generation sequencing and personalised tumour-informed droplet PCR ...

During his presentation at the J.P. Morgan Healthcare Conference last week, Incyte CEO Hervé Hoppenot took investors on a ...

Adding a monoclonal antibody cocktail to the standard treatment for inoperable liver cancer nearly doubled the amount of time ...

The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the body or cannot be surgically removed.

Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.

More testing is needed, but if the same results are seen in humans, it could transform treatment of the disease.

The Quezon City government recently launched a community-based cervical cancer screening program as part of the enactment of City Ordinance SP-3285 or the Quezon City Integrated Cancer Control ...

Discover which popular foods will be affected by the FDA's new ban on Red No. 3, the synthetic dye that adds a vibrant pop of ...

Scientists have developed a single-dose treatment for breast cancer that eliminates small tumors and significantly shrinks ...